Primary Site >> Stomach Cancer
Gene >> MUC16
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: [Serum CA125 in gastric cancer patients with peritoneal dissemination]. PMID: 3480421 |
Ref: [Combination of adoptive immunotherapy and chemotherapy against advanced cancer with peritoneal dissemination]. PMID: 2172423 Ref: A simple procedure for isolation of tumor-associated antigens by affinity chromatography using fucose-specific Aleuria aurantia lectin. PMID: 2210805 |
Ref: [Establishment and characterization of a human scirrhus type gastric cancer cell line, GCIY, producing CA19-9]. PMID: 1653599 Ref: [Serum CA125 in patients with gastric cancer or colon cancer was transiently increased after curative resection: preliminary report]. PMID: 1770940 |
Ref: Markers of surface mucous cell type human gastric cancer cells: galactose oxidase-Schiff reactive mucins, monoclonal antibody SH-9 reactive mucins and cathepsin E. PMID: 8237369 |
Ref: Alteration of immunoreactivity by hydrated autoclaving, microwave treatment, and simple heating of paraffin-embedded tissue sections. PMID: 7516673 |
Ref: Increase in the circulating level of hepatocyte growth factor in gastric cancer patients. PMID: 9043023 Ref: [Two cases of advanced gastric cancer effectively treated with chemotherapy of 5-fluorouracil, cisplatin and cytarabine]. PMID: 9170530 |
Ref: Tumor markers CEA, CA19-9 and CA125 in monitoring of response to systemic chemotherapy in patients with advanced gastric cancer. PMID: 10678558 |
Ref: [A case of stage IV gastric cancer with multiple liver metastases and carcinomatous ascites responding to TS-1 for six months before progression]. PMID: 11201387 |
Ref: Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence. PMID: 12143226 |
Ref: [A case of nonresected gastric cancer with peritoneal dissemination maintained on TS-1, cisplatin (CDDP) and docetaxel combination chemotherapy with good QOL]. PMID: 16484867 |
Ref: Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients. PMID: 17226046 |
Ref: Investigation of serum tumor markers in the diagnosis of gastric cancer. PMID: 21510322 Ref: Screening the gastric cancer related tumor markers from multi-tumor markers protein chip with kappa coefficient and cost-effectiveness analysis. PMID: 21661444 |
Ref: Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer. PMID: 23672279 |
Ref: Clinical value of serum tumor markers CA19-9, CA125 and CA72-4 in the diagnosis of pancreatic carcinoma. PMID: 24649344 Ref: Quantitative comparisons of summary receiver operating characteristics (sROC) curves among conventional serological tumor biomarkers for predicting gastric cancer in Chinese population. PMID: 24906604 Ref: Combined use of lysyl oxidase, carcino-embryonic antigen, and carbohydrate antigens improves the sensitivity of biomarkers in predicting lymph node metastasis and peritoneal metastasis in gastric cancer. PMID: 25060181 Ref: CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer. PMID: 25086284 Ref: The effects of PTBP3 silencing on the proliferation and differentiation of MKN45 human gastric cancer cells. PMID: 25119103 Ref: Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy. PMID: 25543664 Ref: Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer. PMID: 26176088 |
Ref: A Detailed Immunohistochemical Analysis of a Large Series of Cervical and Vaginal Gastric-type Adenocarcinomas. PMID: 26685087 Ref: Diagnostic significance of soluble human leukocyte antigen-G for gastric cancer. PMID: 26788811 Ref: Clinicopathological features and prognosis of gastric cancer in young patients. PMID: 27418046 Ref: Prognostic values of normal preoperative serum cancer markers for gastric cancer. PMID: 27533455 |
Ref: Higher Numbers of T-Bet+ Tumor-Infiltrating Lymphocytes Associate with Better Survival in Human Epithelial Ovarian Cancer. PMID: 28214872 Ref: SLC3A2, antigen of mAb 3G9, promotes migration and invasion by upregulating of mucins in gastric cancer. PMID: 29179459 Ref: The red distribution width and the platelet distribution width as prognostic predictors in gastric cancer. PMID: 29262773 |
Ref: Clinicopathological features and prognosis in elderly gastric cancer patients: a retrospective cohort study. PMID: 29559793 Ref: Antibody-sandwich ELISA analysis of a novel blood biomarker of CST4 in gastrointestinal cancers. PMID: 29636621 Ref: Prognostic Value of Combination of Pretreatment Red Cell Distribution Width and Neutrophil-to-Lymphocyte Ratio in Patients with Gastric Cancer. PMID: 29643918 Ref: Simultaneous quantitation of carbohydrate antigen 125 and carcinoembryonic antigen in human serum via time-resolved fluoroimmunoassay. PMID: 29729233 Ref: Five common tumor biomarkers and CEA for diagnosing early gastric cancer: A protocol for a network meta-analysis of diagnostic test accuracy. PMID: 29742692 Ref: Multilayered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT/betacatenin signaling activation (Review). PMID: 29786110 Ref: MUC16 Mutations and Prognosis in Gastric Cancer: A Little Goes a Long Way. PMID: 30098141 Ref: Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer. PMID: 30098163 Ref: Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas. PMID: 30236127 |